|
|
|
|
|
|
|
|
|
09.02.26 - 15:13
|
EU verbietet Firmen Vernichtung unverkaufter Kleidung (DPA-AFX)
|
|
|
BRÜSSEL (dpa-AFX) - Große Mode-Unternehmen in der EU dürfen nicht verkaufte Kleidungsstücke und Schuhe ab dem 19. Juli nur noch unter ganz bestimmten Bedingungen vernichten. Für mittlere Unternehmen soll die Regel ab 2030 gelten, die die EU-Kommission ......
|
|
|
|
|
|
|
|
|
|
|
09.02.26 - 15:06
|
Portfoliomanager Matthew Moberg im Interview: „Echte Innovationen erzeugen nicht isolierte Effizienzgewinne, sondern neue Möglichkeitsräume“ (Das Investment)
|
|
|
Von schwebenden Zellen bis zu Satelliten-KI: Matthew Moberg, Portfoliomanager bei Franklin Equity Group, über Innovationen, die Märkte verändern und Investitionschancen eröffnen.Der von Franklin Equity Group vierteljährlich herausgebrachte Marktbericht Innovation Insights Quarterly zeichnet in seiner aktuellen Ausgabe ein Panorama von Technologien, die nicht nur bestehende Probleme lösen, sondern ganze Entwicklungspfade neu definieren könnten – von der Zellbiologie über Logistik bis hin zur KI-Infrastruktur im Orbit. Matthew Moberg erklärt, was langfristige Investoren über diese Innovationen wissen sollten. DAS INVESTMENT: Herr Moberg, der vor wenigen Tagen erschienene Quartalsbericht stellt eine klare These auf:...In Verbindung stehende Nachrichten:Infrastruktur-Aktien für das Portfolio: "KI und Dekarbonisierung treiben die Infrastrukturmärkte 2026"Ausblick auf indische Aktien 2026: Indiens Wachstumsstory: Aufbruchstimmung nach turbulenter PhaseExpansion in Asien und Lateinamerik...
|
|
|
|
|
09.02.26 - 15:06
|
Bruce J. Schnicker, Ph.D., Joins Pivot Bio as Vice President of Product Development (Business Wire)
|
|
|
Industry Veteran Brings Deep Experience in Agricultural InnovationMINNEAPOLIS--(BUSINESS WIRE)--Pivot Bio, one of the world's leading innovative agtech companies, today announced Bruce Schnicker has joined the company as vice president of product development. In this role, Schnicker will be responsible for overseeing product development lifecycle from early-stage grower-oriented discovery to solution design and commercialization. He will report to Travis Frey, chief technology officer.
Schnicker joins Pivot Bio from Bayer, where he led multiple organizations focused on developing and deploying agricultural innovations across genetics, traits, crop management systems, and digital technologies, spanning both R&D and commercial platforms. Over more than two decades, he has driven impact across more than twenty crops and led global teams throughout North, Central, and South America, Europe, Africa, Asia, Australia, and New Zealand.
“Beyond Bruce's deep experience in agtech, he's a passionate leader who h...
|
|
|
09.02.26 - 15:06
|
American Business Bank Ranked in 2026 Best 50 Top Performing Companies Traded on OTCQX (Business Wire)
|
|
|
LOS ANGELES--(BUSINESS WIRE)--AMERICAN BUSINESS BANK (OTCQX: AMBZ) (“ABB”) is pleased to announce it has been ranked in the OTCQX Best 50, a ranking of the top performing companies traded on the OTCQX Best market last year, published January 15, 2026.
“We are honored and grateful to be recognized alongside so many successful and thriving companies on this list. This acknowledgment is a true reflection of our team's continued dedication to serving the best middle-market businesses across Southern California,” said Leon Blankstein, Chief Executive Officer, President and Director of ABB.
ABB holds a large regional footprint in Southern California, serving closely held middle market companies with customized financial needs. ABB is focused on delivering flexible, innovative financial solutions to help businesses grow and navigate an evolving marketplace. The Bank offers a comprehensive suite of services tailored to the needs of regional businesses, including business loans, lines of credit, treasury ...
|
|
|
|
|
09.02.26 - 15:03
|
Interoil completes strategic exit from Argentina (GlobeNewswire EN)
|
|
|
Oslo, Norway – February 9, 2025 – Interoil Exploration and Production ASA (“Interoil” or the “Company”) announces that it has completed a strategic decision to exit its conventional operations in Argentina. The exit covers the interests held by Interoil in the country in all of the Santa Cruz Sur joint operations (due to expire between April and August 2026), and the La Brea Block, as well as the right to challenge the termination of the Mata Magallanes Oeste (MMO) production concession and the Cañadón Ramírez (CR) exploration block....
|
|
|
09.02.26 - 15:01
|
KONE Corporation′s long-term incentive plan: transfer of shares and change in holding of treasury shares (Cision)
|
|
|
KONE Corporation, stock exchange release, February 9, 2026, at 03:55 p.m. EET
KONE Corporation's long-term incentive plan: transfer of shares and change in holding of treasury shares
The Board of Directors of KONE Corporation has decided on 5 February, 2026 based on the authorization given by the company's annual general meeting in 2025, on a directed share issue without consideration to pay the share reward under the company's performance based long-term incentive plan 2023-2025 and restricted share plans 2023 and 2024.
In the share issue on 9 February 2026, KONE Corporation has...
|
|
|
09.02.26 - 15:01
|
BMW und E.ON starten V2G-Angebot für Privatkunden (Electrive)
|
|
|
Die BMW Group und E.ON gehen nach der Ankündigung des ihres kommerziellen Vehicle-to-Grid-Angebots (V2G) im September 2025 nun den nächsten Schritt: Ab sofort können Privatkundinnen und -kunden das vollständige Produktpaket bestellen....
|
|
|
|
|
09.02.26 - 15:01
|
V2G ab sofort für BMW iX3 bestellbar (Elektroauto-News)
|
|
|
Angekündigt hatte BMW es bereits, nun ist es Bestellbar: Das Paket für V2G inklusive Wallbox und Stromtarif. Wer schnell bestellt, bekommt 700 Euro Bonus.
Der Beitrag V2G ab sofort für BMW iX3 bestellbar erschien zuerst auf Elektroauto-News.net....
|
|
|
09.02.26 - 15:01
|
Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout (Cision)
|
|
|
Swedish Orphan Biovitrum AB (publ) Sobi® (STO:SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by Sobi.
Upon completion of the transaction, Sobi has acquired all outstanding shares of Arthrosi's common stock and common stock equivalents.
Arthrosi Therapeutics is a private late-stage biotechnology company focused on developing a next-generation treatment for gout. The acquisition strengthens Sobi's gout franchise by adding pozdeutinurad (AR882), an investigational next-generation, once-daily oral URAT1 inhibitor currently...
|
|
|
|
Alle News zu Europa 6012.827 -0.03% (E.St.50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
